Chemical Structure (Fabior 01)
Fabior Aerosol, Foam
Product Images NDC 51862-295
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Fabior (NDC 51862-295). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Mayne Pharma, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure A (Fabior 02)
Figure B (Fabior 03)
Figure C (Fabior 04)
Figure D (Fabior 05)
Figure E (Fabior 06)
Principal Display Panel (50 gram Can Carton)
This is a description of a medication called Fabior Foam. It is a prescription medication that is used only topically (for external use only). The foam comes in a can with a pressurized hydrocarbon propellant that dispenses the medication. The can should be shaken before use and only used as prescribed by a physician. It contains tazarotene, butylated hydroxytoluene, ceteareth-12, citric acid anhydrous, disopropyl adipate, light mineral oil, potassium ditrate monohydrate, potassium sorbate, purified water, and ascorbic acid. The medication is flammable, so it should be kept away from fire and sources of heat, and should not be punctured or stored above 49°C (120°F). The medication should be stored upright and protected from freezing. The medication was distributed by Mayne Pharma and is manufactured in Canada. If there is an adverse reaction to the medication, Mayne Pharma should be contacted.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
